[Event Report] The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Policy Dialogue Event “Challenges and Prospects for the Improving Patient Access to Genomic Cancer Medicine” (October 11, 2023)
date : 11/6/2023
Tags: NCDs, Precision Cancer Medicine
![[Event Report] The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Policy Dialogue Event “Challenges and Prospects for the Improving Patient Access to Genomic Cancer Medicine” (October 11, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/ncd-pcm-20231011-top.png)
Health and Global Policy Institute (HGPI) held the policy dialogue event “Challenges and Prospects for the Improving Patient Access to Genomic Cancer Medicine” on October 11, 2023.
Personalized cancer medicine, in which treatment is tailored to individuals in accordance with the genetic mutations and other characteristics of their cancer, is expected to play an important role in the future.
We believe that among personalized cancer care, genomic cancer medicine can be delivered more broadly to the public as several years have now passed since Comprehensive Genomic Profiling (CGP; or cancer gene panel tests) was granted health insurance coverage in 2019, and those serving in clinical settings are starting to gain experience with this form of medicine.
Moreover, the “Bill on the Comprehensive and Systematic Promotion of Measures to Ensure the Public Can Access High-Quality, Suitable Genomic Medicine with Peace of Mind” (a bill to promote genomic cancer medicine) was passed in June 2023.
However, there are policy challenges with respect to delivering genomic cancer medicine may be not only issues that are universally faced by Japanese healthcare, but also many issues that are unique to cancer genome medicine.
HGPI held, Policy Dialogue Event “Challenges and Prospects for the Improving Patient Access to Genomic Cancer Medicine” on October 11, 2023 to deepen discussions based on Policy Recommendations “Improving Patient Access to Genomic Cancer Medicine policy proposal” (August 10, 2023) and to serve as a bridge for implementation into society.
[Event Overview]
- Date & Time: Wednesday, October 23, 2023; form 13:30 to 15:00 JST
- Format: Hybrid (In-Person and Online (Zoom Webinars))
- Venue: Zenkoku Choson Kaikan
- Sponsors (Japanese Order):
MSD K.K.
National Graduate Institute for Policy Studies (GRIPS) Global Health Innovation Policy Program (GHIPP)
Chugai Pharmaceutical Co., Ltd.
Bayer Yakuhin, Ltd.
Janssen Pharmaceutical K.K.
[Program] (Titles omitted, Japanese order)
13:30-13:35 | Opening Remarks and Introduction |
Haruka Sakamoto (Senior Manager, HGPI) | |
13:35-14:05 | Panel Discussion (1) “Measures needed to make Genomic Cancer medicine more common” |
Shinsuke Amano (Executive Director, Japan Federation of Cancer Patient Groups/Executive Director, Group Nexus Japan) Moderator: Osamu Takemoto (Program Specialist, HGPI) |
|
![]() ![]() |
|
14:05-14:15 | Free Discussion |
14:15-14:45 | Panel Discussion (2) “Measures to improve patient access to genomic cancer medicine in rural area” |
Naomi Sakurai (President, Cancer Solutions Co., Ltd) Moderator: Shu Suzuki (Senior Associate, HGPI) |
|
|
|
14:45-14:55 | Free Discussion |
14:55-15:00 | Closing Remarks |
Kiyoshi Kurokawa (Chairman, HGPI) |
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)